(Q40151319)

English

Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals

scientific article published on 21 November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

ORCID Public Data File 2021

author name string

Y Lynn Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Joong W Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Jonathan S Kui

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Amy Chadburn

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Nicholas C P Cross

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Daniel M Knowles

6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Morton Coleman

7

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

publication date

21 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Acta Haematologica

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

118

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

209-214

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

https://api.crossref.org/works/10.1159%2F000111532

21 January 2018

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1159%2F000111532

21 January 2018

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1159%2F000111532

21 January 2018

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1159%2F000111532

21 January 2018

The role of Janus kinases in haemopoiesis and haematological malignancy

1 reference

https://api.crossref.org/works/10.1159%2F000111532

21 January 2018

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

1 reference

https://api.crossref.org/works/10.1159%2F000111532

21 January 2018

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1159%2F000111532

21 January 2018

Identifiers

10.1159/000111532

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40151319&oldid=1887367876"